![](/img/cover-not-exists.png)
Chronic myelogenous leukemia in T cell lymphoid blastic phase achieving durable complete cytogenetic and molecular remission with imatinib mesylate (STI571; Gleevec) therapy
Ehab Atallah, Moshe Talpaz, Susan O'brien, Mary Beth Rios, Jie Qiang Guo, Ralph Arlinghaus, Sofia Fernandes-Reese, Hagop KantarjianVolume:
94
Year:
2002
Language:
english
Pages:
4
DOI:
10.1002/cncr.10576
File:
PDF, 57 KB
english, 2002